Baxter International Inc (BAX)
35.79
-0.01
(-0.03%)
USD |
NYSE |
Nov 05, 11:23
Baxter International Research and Development Expense (Annual): 667.00M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 667.00M |
| December 31, 2022 | 602.00M |
| December 31, 2021 | 531.00M |
| December 31, 2020 | 521.00M |
| December 31, 2019 | 595.00M |
| December 31, 2018 | 654.00M |
| December 31, 2017 | 615.00M |
| December 31, 2016 | 646.00M |
| December 31, 2015 | 603.00M |
| December 31, 2014 | 610.00M |
| December 31, 2013 | 582.00M |
| December 31, 2012 | 1.081B |
| December 31, 2011 | 946.00M |
| December 31, 2010 | 915.00M |
| December 31, 2009 | 917.00M |
| Date | Value |
|---|---|
| December 31, 2008 | 868.00M |
| December 31, 2007 | 760.00M |
| December 31, 2006 | 614.00M |
| December 31, 2005 | 533.00M |
| December 31, 2004 | 517.00M |
| December 31, 2003 | 553.00M |
| December 31, 2002 | 501.00M |
| December 31, 2001 | 426.00M |
| December 31, 2000 | 378.00M |
| December 31, 1999 | 332.00M |
| December 31, 1998 | 323.00M |
| December 31, 1997 | 339.00M |
| December 31, 1996 | 340.00M |
| December 31, 1995 | 345.00M |
| December 31, 1994 | 343.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
521.00M
Minimum
2020
667.00M
Maximum
2023
583.20M
Average
595.00M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Haemonetics Corp | 54.44M |
| Accuray Inc | 49.73M |
| Masimo Corp | 175.20M |
| Insulet Corp | 205.00M |